Abstract
Vitamin D is increasingly becoming recognized as an important physiological regulator with pleiotropic functions outside of its classical role in skeletal homeostasis. A growing body of clinical evidence highlights the prevalence and risks of vitamin D deficiency in patients suffering from chronic hepatitis C infection, and vitamin D supplementation has been proposed as an adjunct to current standards of care. This review considers the experimental evidence for the anti-inflammatory, antifibrotic and antiviral effects of vitamin D, and discusses the therapeutic potential of vitamin D supplementation to protect against liver disease progression and improve responses to treatment.
Original language | English |
---|---|
Pages (from-to) | 184-189 |
Number of pages | 6 |
Journal | Journal of Hepatology |
Volume | 58 |
Issue number | 1 |
DOIs |
|
State | Published - Jan 2013 |
Keywords
- Hepatitis C
- Vitamin D